Ullah H, Huma S, Yasin G, Ashraf M, Tahir N, Tahir Uddin Q, Shabana H, A R Hussein M, Shalaby A, Mossaad Alsayyad M, Said A, Farahat A, Hamed HI, Ayoub HSA, Imam MS, Elmahdi E. Comparison of different severity scores in correlating hemoglobin levels with the severity of hepatic decompensation: An observational study. World J Hepatol 2025; 17(1): 101212 [DOI: 10.4254/wjh.v17.i1.101212]
Corresponding Author of This Article
Sarwat Huma, Doctor, MBBS, Academic Fellow, Research Fellow, Health Professions Education, Health Services Academy, Health Services Academy Park Road, Chak Shahzad, Islamabad 44000, Pakistan. sarwathuma007@gmail.com
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Observational Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Hepatol. Jan 27, 2025; 17(1): 101212 Published online Jan 27, 2025. doi: 10.4254/wjh.v17.i1.101212
Table 1 Child-Pugh score
Variable
1 point
2 points
3 points
Interpretation
Serum albumin (mg/dL)
> 3.5
2.8–3.5
< 2.8
Sum of points: 5–6 = A; 7–9 = B; > 9 = C
Serum bilirubin (mg/dL)
< 2
2–3
> 3
International normalized ratio
< 1.7
1.7–2.3
> 2.3
Ascites
None
Mild
Marked
Encephalopathy
None
Grade 1 and 2
Grade 3 and 4
Table 2 Interpretation of model of end-stage liver disease score
Model of end-stage liver disease score
3 months mortality (percentage)
9 or less
1.9
10–19
6
20–29
19.6
30–39
52.6
40 or above
71.3
Table 3 Demographic and clinical characteristics of study population
Variable
Number
Mean (SD)
Percentage
Minimum
Maximum
Age
-
58.8 (17.4)
-
15
90
Gender
Male = 405, female = 247
-
62.1, 37.9
-
-
Serum sodium (mEq/L)
-
128.8 (6.2)
-
120
149
Serum bilirubin (mg/dL)
-
5.6 (5.0)
-
0.8
25.3
Serum albumin (mg/dL)
-
3.0 (0.9)
-
1.2
4.9
Serum creatinine (mg/dL)
-
2.1 (1.1)
-
0.6
5.0
International normalized ratio
-
1.9 (0.7)
-
1.1
6.4
Hemoglobin (g/dL)
-
11.1 (2.1)
-
5.3
17.2
Child-Pugh score
-
10.5 (2.6)
-
6
15
MELD score
-
23 (9)
-
5
48
MELD-Na score
-
27 (9)
-
1
49
Table 4 Comparison of hemoglobin levels across Child-Pugh classes
Child-Pugh class
Number of patients
Mean hemoglobin (g/dL)
SD (g/dL)
Analysis of variance (F value)
P value
A
41
11.8
2.1
20.011
0.001
B
211
11.7
1.9
C
400
10.6
2.1
Total
652
11.1
2.1
Table 5 Comparison of hemoglobin levels across model of end-stage liver disease score group
Group
Model of end-stage liver disease score range
Number of patients
Mean hemoglobin level (g/dL)
SD (g/dL)
Analysis of variance (F value)
P value
1
< 10
33
12.6
1.8
13.042
0.001
2
10–19
236
11.5
2.0
3
20–29
165
10.7
2.0
4
30–39
181
10.7
1.9
5
> 39
37
9.8
1.9
Total
652
11.1
2.0
Table 6 Comparison of hemoglobin levels across model of end-stage liver disease-Na score groups
Group
Model of end-stage liver disease-Na score range
Number of patients
Mean hemoglobin level (g/dL)
SD (g/dL)
Analysis of variance (F value)
P value
1
< 10
22
12.0
2.1
9.6
.001
2
10-19
119
11.5
2.0
3
20-29
192
11.4
2.1
4
30–39
274
10.7
1.9
5
> 39
45
10.1
1.9
Total
652
11.1
2.0
Table 7 Correlation of hemoglobin levels with clinical severity scores (Child-Pugh, model of end-stage liver disease, and model of end-stage liver disease-Na)
Correlation (Pearson)
R value
P value
Hemoglobin vs Child-Pugh
-0.21
< 0.01
Hemoglobin vs MELD
-0.26
< 0.01
Hemoglobin vs MELD-Na
-0.25
< 0.01
Citation: Ullah H, Huma S, Yasin G, Ashraf M, Tahir N, Tahir Uddin Q, Shabana H, A R Hussein M, Shalaby A, Mossaad Alsayyad M, Said A, Farahat A, Hamed HI, Ayoub HSA, Imam MS, Elmahdi E. Comparison of different severity scores in correlating hemoglobin levels with the severity of hepatic decompensation: An observational study. World J Hepatol 2025; 17(1): 101212